CPST: Capstone Turbine announced a new distributor on Tuesday when the company named PFI Energy & Ecology as their distributor for Argentina.
Capstone, the maker of low-emission and 'clean' microturbine energy systems, is growing in presence around the world as investors wait for the potential to grow the bottom line of the company.
I still like this stock as a 'green' play for the portfolio - especially when the stock trades down towards a dollar - but I have some scepticism about the chances of this company becoming cash flow break even any time soon. There's no doubt, however, that the business is growing and the potential for big things down the road is there. I've discussed some of that potential in previous posts.
I've still got a long term outlook with this one and it's a stock to watch as the country - and the world - goes green.
Disclosure: VFC is long CPST.
KERX: Shares of Keryx Biopharmaceuticals spiked as high as $2.46 on Thursday morning after the company announced the initiation of another Phase II study for Perifosine, this time to measure the drug's effectiveness in treating relapsed or refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).
The news offers insight into the additional potential of Perifosine, but investors shouldn't get too excited just yet because it is only the very beginning stages of a Phase II trial.
The company is currently preparing for the initiation of Phase III trials involving both Perifosine and Zerenex; the progression of those trials hold the more immediate potential to influence the price of the stock.
After selling into the recent spike to over three bucks and buying back in for just over two - in an attempt to get closer to playing with this one on house money, I'm back in accumulation mode with an eye towards the future.
Disclosure: VFC is long KERX.